Spots Global Cancer Trial Database for viral disease
Every month we try and update this database with for viral disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients | NCT02724254 | Condyloma | AP611074 5% gel AP611074 matchi... | 18 Years - 55 Years | Vaxart | |
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. |